Trademark Overview
On Tuesday, November 7, 2017, a trademark application was filed for ERZYGA with the United States Patent and Trademark Office. The USPTO has given the ERZYGA trademark a serial number of 87674359. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, January 26, 2018. This trademark is owned by JOHNSON & JOHNSON. The ERZYGA trademark is filed in the Pharmaceutical Products category with the following description:
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives